enVVeno Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of enVVeno Medical generated cash of -$18,858,000, which is less than the previous year. Cash used in financing activities reached the amount of $25,791,000 last year. Net change in cash is therefore -$935,000.
Cash Flow
| 2015 | -2.01M | -77.62K | 3.62M |
|---|---|---|---|
| 2016 | -3.08M | -705.26K | 2.26M |
| 2017 | -4.20M | 165.31K | 4.05M |
| 2018 | -6.35M | -12.42K | 9.03M |
| 2019 | -5.89M | -363.89K | 5.63M |
| 2020 | -7.67M | -180.29K | 15.07M |
| 2021 | -11.84M | -367.89K | 57.60M |
| 2022 | -15.61M | -34.55M | 0 |
| 2023 | -18.85M | -7.86M | 25.79M |
NVNOW Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.55M | 54.72M | 9.33M | 2.11M | 2.74M | 77.68K | 56.51K | 1.58M | 58.02K |
Operating activities | |||||||||
Net income | -23.51M | -24.66M | -16.52M | -9.13M | -7.62M | -13.04M | -7.79M | -3.38M | -1.60M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 546K | 525K | 452.90K | 383.97K | 396.66K | 133.41K | 139.21K | 151.17K | 125.42K |
Stock-based compensation expense | 5.19M | 8.99M | 5.99M | 881.21K | 941.96K | 0 | 878.40K | 1.51M | 0 |
| Deferred income tax benefit | 5.19M | 8.99M | 5.99M | 881.21K | 941.96K | 0 | 878.40K | 1.51M | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 32.02K | 3.15K | -11.68K | 309K | 25.24K |
Inventories | 0 | 0 | 0 | 0 | 0 | -217.03K | 90.90K | -213.17K | 171.90K |
Accounts payable | -221K | 88K | -832.70K | 169.17K | 144.06K | -294.12K | 545.38K | -76.32K | -83.53K |
Cash generated by operating activities | -18.85M | -15.61M | -11.84M | -7.67M | -5.89M | -6.35M | -4.20M | -3.08M | -2.01M |
Investing activities | |||||||||
Purchases Of Investments | -56.52M | -48.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -33K | -115K | -367.89K | -180.29K | -363.89K | -12.42K | -10.93K | -373.61K | -2.62K |
Acquisitions Net | 0 | 34.43K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -7.86M | -34.55M | -367.89K | -180.29K | -363.89K | -12.42K | 165.31K | -705.26K | -77.62K |
Financing activities | |||||||||
Common Stock Issued | 25.79M | 0 | 57.60M | 10.41M | 5.63M | 7.65M | 1.08M | 0 | 1.87M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -312.7K | 0 | -1.24M | 2.97M | -186.62K | 698.51K |
Cash used in financing activities | 25.79M | 0 | 57.60M | 15.07M | 5.63M | 9.03M | 4.05M | 2.26M | 3.62M |
Net Change In Cash | -935K | -50.17M | 45.39M | 7.21M | -623.35K | 2.66M | 21.17K | -1.52M | 1.52M |
Cash at end of period | 3.62M | 4.55M | 54.72M | 9.33M | 2.11M | 2.74M | 77.68K | 56.51K | 1.58M |
| Data source | Data source | Data source | Data source | Data source | Data source |